Squamous cell carcinoma of rectum
MONDO:0018515A very rare rectal carcinoma characterized by the presence of a malignant squamous cell infiltrate.
Also known as: rectal squamous carcinoma, rectal squamous cell cancer, rectal squamous cell carcinoma, rectum squamous cell carcinoma, squamous carcinoma of rectum, squamous carcinoma of the rectum, squamous cell carcinoma of rectum, squamous cell carcinoma of the rectum
2940 clinical trials for this condition and its sub-types, 8 tagged with Squamous cell carcinoma of rectum itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Squamous cell carcinoma of rectum
-
Anal squamous cell carcinoma 40 trials · 49 incl. sub-types
4 sub-types
- Anal canal squamous cell carcinoma 12 trials
- Anal margin squamous cell carcinoma 4 trials
- Anus basaloid carcinoma 3 trials
- Anal verrucous carcinoma 0 trials
-
Rectal adenosquamous carcinoma 0 trials
-
Rectal cloacogenic carcinoma 0 trials
-
New HPV vaccine combo aims to fight Hard-to-Treat cancers
Disease control CompletedThis study tests an HPV vaccine (PRGN-2009) alone or with a drug called M7824 in people with HPV-positive cancers like cervical, anal, and throat cancers. The goal is to find a safe dose and see if the combination boosts the immune system's attack on tumors. The trial includes 39…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Triple immunotherapy attack shows promise against Hard-to-Treat HPV cancers
Disease control CompletedThis study tests a combination of three immunotherapy drugs—PDS0101, M7824, and NHS-IL12—in people with advanced HPV-related cancers such as cervical, anal, and throat cancers. The goal is to see if the mix can shrink tumors or stop them from growing. Participants receive the dru…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC